Cargando…
Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
In recent studies, the reported prevalence of heterozygous familial hypercholesterolemia (FH) has been higher than in previous reports. Although cascade genetic screening is a good option for efficient identification of affected patients, diagnosis using only clinical criteria is more common in real...
Autor principal: | Lee, Sang-Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368119/ https://www.ncbi.nlm.nih.gov/pubmed/28116871 http://dx.doi.org/10.3803/EnM.2017.32.1.36 |
Ejemplares similares
-
An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022) -
Impact of Severe Hypercholesterolemia on Cardiovascular Risk in Individuals With or Without Diabetes Mellitus
por: Lee, Chan Joo, et al.
Publicado: (2022) -
Molecular diagnosis methods in familial hypercholesterolemia
por: Moldovan, Valeriu, et al.
Publicado: (2020) -
2022 Consensus statement on the management of familial hypercholesterolemia in Korea
por: Lee, Chan Joo, et al.
Publicado: (2022) -
2022 Consensus Statement on the Management of Familial Hypercholesterolemia in Korea
por: Lee, Chan Joo, et al.
Publicado: (2022)